"This data is very encouraging and represents the real-world effectiveness of these newer therapies, which include immunotherapies and targeted therapies."
ProMedica has agreed to make two outstanding payments to University of Toledo College of Medicine and Life Sciences after the Ohio AG threatened to sue.